NASDAQ · MEDS
Healthcare · Medical - Pharmaceuticals
$0.89
Up+$0.04 (+4.82%)
Updated Sep 11, 2026, 7:25 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
MEDS closed at $0.89 after 20 trading sessions, down 40.13% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $0.8799 | $0.903 | $0.8501 | $0.892 | 80K |
| Sep 9, 2026 | $0.871 | $0.95 | $0.851 | $0.851 | 148.64K |
| Sep 8, 2026 | $0.9153 | $0.9188 | $0.8526 | $0.8711 | 136.68K |
| Sep 4, 2026 | $0.975 | $1.04 | $0.915 | $0.916 | 312.92K |
| Sep 3, 2026 | $1.02 | $1.0299 | $0.951 | $0.9611 | 52.11K |
| Sep 2, 2026 | $0.9696 | $1.05 | $0.9321 | $1.03 | 128.72K |
| Sep 1, 2026 | $0.94 | $1.02 | $0.9202 | $0.99 | 138.09K |
| Aug 31, 2026 | $0.878 | $1.05 | $0.8225 | $0.963 | 7.83M |
| Aug 28, 2026 | $1.15 | $1.17 | $0.9602 | $0.9606 | 129.57K |
| Aug 27, 2026 | $1.20 | $1.28 | $1.16 | $1.17 | 284.36K |
| Aug 26, 2026 | $1.35 | $1.3678 | $1.26 | $1.335 | 2.8M |
| Aug 25, 2026 | $1.32 | $1.36 | $1.30 | $1.36 | 42.73K |
| Aug 24, 2026 | $1.38 | $1.39 | $1.30 | $1.30 | 35.95K |
| Aug 21, 2026 | $1.4318 | $1.51 | $1.36 | $1.37 | 69.61K |
| Aug 20, 2026 | $1.43 | $1.4538 | $1.31 | $1.45 | 208.33K |
| Aug 19, 2026 | $1.39 | $1.5684 | $1.34 | $1.43 | 410.62K |
| Aug 18, 2026 | $1.45 | $1.50 | $1.38 | $1.38 | 64.29K |
| Aug 17, 2026 | $1.46 | $1.66 | $1.39 | $1.49 | 325.4K |
| Aug 14, 2026 | $1.53 | $1.57 | $1.43 | $1.48 | 68.14K |
| Aug 13, 2026 | $1.36 | $1.54 | $1.2551 | $1.49 | 179.54K |
The latest Smart Investors Daily articles mentioning MEDS.
MEDS research
Company profile and research snapshot.
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 16, 2023 | EF Hutton | Buy | — |
| Mar 28, 2023 | Maxim Group | Buy | — |
| Dec 9, 2021 | EF Hutton | Buy | — |
| Dec 3, 2020 | National Securities | Buy | — |
No generated briefing is available yet.
Yahoo · Aug 17, 2026
Revenues grew 14% reaching $1.779M in Q2/26, beating management projections Corporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from ‘WGRX' to ‘MEDS' on NASDAQ Capital ...
Benzinga · Aug 17, 2026
DataMEDS AI (NASDAQ:MEDS) reported quarterly losses of $(7.13) per share. This is a 32.04 percent decrease over losses of $(5.40) per share from the same period last year. The company reported $1.780 million in sales
Yahoo · Aug 14, 2026
TAMPA, FL / ACCESS Newswire / August 14, 2026 /DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx™ ...
Yahoo · Aug 12, 2026
GLP-1 agonist drugs now available Integration of online store CorexaRx.com into Health Lives Here app now complete Medical foods Forzet™ & Galectovid™, and dietary supplement Tollovid® now available Revenue stabilized above $600,000 ...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MEDS.
